Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine

Name: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine
License: Public Domain

University of Washington

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

her2-positive breast cancer, recurrent breast cancer, recurrent non-small cell lung cancer, recurrent ovarian epithelial cancer, recurrent ovarian germ cell tumor, stage iv breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 651122
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.